Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia.
The last earnings update was 87 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Medlab Clinical. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Medlab Clinical's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medlab Clinical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Biotechs industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Medlab Clinical's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Medlab Clinical's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare Medlab Clinical's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if Medlab Clinical is high growth as no earnings estimate data is available.
Unable to determine if Medlab Clinical is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Medlab Clinical's filings and announcements here.
Medlab Clinical's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
Dr. Sean Michael Hall serves as the Chief Executive Officer and Managing Director of Medlab Clinical Limited. Dr. Hall started Medlab in August 2012. Dr. Hall has over 20 years of experience in the Australian Healthcare and food industries (nutraceutical sales and development) and early phase drug discovery in Australia and Asia. Dr. Hall was one of the founders of FIT-BioCeuticals LTD (www.fit-bioceuticals.com.au) and through his management and guidance, BioCeuticals (leading brand) expanded into a leadership role in the Australian Health Care community. His focus on leadership and innovation has led to the authoring of multiple patents, written peer reviewed articles and lectures at scientific conferences. Dr. Hall has been a Director of Medlab Clinical Limited since April 17, 2014. Dr. Hall serves as a Board Member of the International Probiotics Association (IPA). Dr. Hall is an active member of Medicines Australia, American Federation for Medical Research (AFMR), American Academy of Anti-Aging Medicine (A4M), AusBiotech and a member of the Scientific Advisory Board for BITs Life Science China. Dr. Hall has co-authored a number of peer-reviewed industry papers, lectured at scientific events and developed many patented products. Dr. Hall is the 2012 Finalist Australian Growth Company Awards, CEO Exit of the Year for his trade sale to Blackmores. Dr. Hall has completed Executive Education at Harvard Graduate School of Business. He holds B.A(Psych), MBA and MD.
Sean's compensation has been consistent with company performance over the past year.
Sean's remuneration is lower than average for companies of similar size in United States of America.
Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.